Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 1/20 | 0.65 |
| ▸ | CA7 | P43166 | 1/20 | 0.65 |
| ▸ | CA9 | Q16790 | 1/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30523913 | 1.00 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2936012 | 0.92 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30702417 | 0.92 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2178296 | 0.86 | CA2 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17075740 | 0.81 | CA1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1943729 | 0.81 | CA1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29880696 | 0.81 | CA1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29004580 | 0.81 | CA1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29066818 | 0.81 | CA1 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28080378 | 0.81 | CA1 (0.45) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506176-B1 | AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PFIZER ITALIA SRL (IT) | 2013-04-24 | — | — | EP | claimed |
| CN-116761834-A | Storage stable epoxy resin composition | 澳泽化学特罗斯特贝格有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-114207024-B | Storage stable epoxy resin composition | 澳泽化学特罗斯特贝格有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-101821246-B | Tetrazole-substituted arylamide derivatives and uses thereof | HOFFMANN LA ROCHE | 2013-05-01 | — | — | CN | disclosed |
| EP-1724294-B1 | POLYMER AND POLYMERIC LUMINESCENT ELEMENT COMPRISING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-11-14 | — | — | EP | disclosed |
| US-8288424-B2 | Substituted tetrahydroimidazopyridine compounds and the use thereof in the treatment of pain and other conditions | GRUENENTHAL GMBH (DE) | 2012-10-16 | — | — | US | disclosed |
| CN-101821246-A | Tetrazole-substituted arylamide derivatives and uses thereof | HOFFMANN LA ROCHE | 2010-09-01 | — | — | CN | disclosed |
| CN-101743224-A | 7-substituted indole mcl-1 inhibitors | ABBOTT LAB | 2010-06-16 | — | — | CN | disclosed |
| US-20090186902-A1 | Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions | GRUENENTHAL GMBH (DE) | 2009-07-23 | — | — | US | disclosed |
| US-20080274303-A1 | Polymer Compound and Polymer Light Emitting Device Using the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1724294-A1 | POLYMER AND POLYMERIC LUMINESCENT ELEMENT COMPRISING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2006-11-22 | — | — | EP | disclosed |
| EP-1403251-A1 | BIS(2-ARYL-5-PYRIDYL) DERIVATIVE | Kowa Co., Ltd. (JP) | 2004-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186902-A1 | Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions | HRH4, TRPV1, QDPR | CA12 2685/4885CA1 827/4885CA2 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.